Drug intelligence / Profile preview

sodium lactate + dextrose monohydrate + calcium chloride + sodium chloride + potassium chloride

Development stage
Approved
Lead developer
Fresenius Kabi
Modality
Small Molecules
Administration
Intravenous
01

Overview

**Sodium lactate + dextrose monohydrate + calcium chloride + sodium chloride + potassium chloride** is a sterile intravenous crystalloid combination solution corresponding to **Lactated Ringer's and 5% Dextrose Injection**. It provides water, electrolytes, lactate as a bicarbonate precursor, and dextrose as a carbohydrate calorie source. Clinically, it is used as a parenteral fluid, nutrient, and electrolyte replenisher for hydration and replacement of extracellular fluid losses in adults and pediatric patients, and can also function as an alkalinizing agent through metabolism of lactate to bicarbonate. This is an established hospital infusion product rather than a novel pipeline asset, with manufacturing and distribution reported for Fresenius Kabi and HP Halden Pharma.

Brand names
Lactated Ringer's and 5% Dextrose InjectionLactated Ringer's and Dextrose 5% Injection
Other names
dextrose in lactated ringer'slactated ringer's and dextrose injectiondextrose and lactated ringer's injectionringer's lactate and dextrose injection
02

Targets

ClC (CLC chloride channel family)L-lactate

Beyond the preview

Go deeper on sodium lactate + dextrose monohydrate + calcium chloride + sodium chloride + potassium chloride.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on sodium lactate + dextrose monohydrate + calcium chloride + sodium chloride + potassium chloride.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call